|  | 
|  | 
|  | 
|  | 
|  | 
| Inactive Indication- | 
| Drug Highest PhasePreclinical | 
| First Approval Ctry. / Loc.- | 
| First Approval Date20 Jan 1800 | 
100 Clinical Results associated with MAP3K11 x JAK3 x TYK2
100 Translational Medicine associated with MAP3K11 x JAK3 x TYK2
0  Patents (Medical) associated with MAP3K11 x JAK3 x TYK2